Cyclo TherapeuticsCYTH
13F holders, Q4 2024 (December 31)22holders +3
3new positions
1sold out
$0.59avg. 13F price*
At the end of Q4 2024, 22 institutions reported holding Cyclo Therapeutics Inc. (CYTH) in their 13F filings, up 3 from Q3 2024. 3 opened new positions and 1 sold out. The largest holders were EPIQ Capital Group, LLC ($407K), Vanguard Group Inc. ($353K) and Founders Fund V Management, LLC ($284K).
- Company
- Cyclo Therapeutics Inc.
- CUSIP
- 23254X201
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $25K |
| Exits | 1 | $3K |
All 13F filers, Q3 2024 → Q4 2024: 44,176 shares bought and 59,931 shares sold, net −15,755 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| EPIQ Capital Group, LLC | 0.11% | Reduce -6.8% | 689,447 | $407K |
| Vanguard Group Inc. | 0.00% | No change | 598,694 | $353K |
| Founders Fund V Management, LLC | 16.84% | No change | 480,708 | $284K |
| Geode Capital Management, LLC | 0.00% | No change | 152,332 | $90K |
| Founders Fund VI Management, LLC | 100.00% | No change | 110,023 | $65K |
| BlackRock, Inc. | 0.00% | Add +0.4% | 83,822 | $49K |
| Two Sigma Securities, LLC | 0.00% | New | 42,541 | $25K |
| State Street Corp. | 0.00% | No change | 39,530 | $23K |
| Northern Trust Corp. | 0.00% | Add +0.1% | 21,736 | $13K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | Reduce -21.9% | 18,285 | $11K |
| UBS Group AG | 0.00% | Reduce -3.8% | 11,987 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +23.9% | 6,684 | $4K |
| Wells Fargo & Company | 0.00% | No change | 4,391 | $3K |
| Morgan Stanley | 0.00% | No change | 1,031 | $608 |
| JPMorgan Chase & Co. | 0.00% | Reduce -0.5% | 193 | $114 |
| Bank of America Corp. | 0.00% | Reduce -82.9% | 170 | $100 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 90 | $53 |
| Osaic Holdings, Inc. | 0.00% | No change | 67 | $39 |
| FMR LLC | 0.00% | New | 30 | $18 |
| SBI Securities Co., Ltd. | 0.00% | — | 11 | $6 |
| BNP Paribas Financial Markets | 0.00% | New | 1 | $1 |
| Royal Bank of Canada | 0.00% | Reduce -9.1% | 746 | $0 |
"% of holder's portfolio" is CYTH's weight in each manager's 13F, not the share of Cyclo Therapeutics Inc. the manager owns.